You are here: Industry Insights > WHO

News List

COVID-19 vaccines expected to go out to poorer countries under COVAX scheme this quarter: WHO expresspharma
January 18, 2021
The COVAX facility has raised $6 billion so far and ordered two billion doses of COVID-19 vaccines with options on one billion more.
SII expects WHO emergency nod for AstraZeneca – Oxford University vaccine soon expresspharma
January 15, 2021
Poonawalla also said his company would start stockpiling millions of doses of the Novavax coronavirus vaccine candidate from around April.
LASA gets WHO GMP certificate for Khed Unit in Ratnagiri expresspharma
January 13, 2021
WHO GMP covers all aspects of production starting from the materials, premises and equipment to the training and personal hygiene of staff.
Speedy delivery of COVID-19 vaccine a huge challenge globally: WHO experts expresspharma
January 06, 2021
As India launches the world’s most ambitious and biggest vaccination drive against COVID-19, the country will encounter the formidable challenge of rapidly scaling up distribution of the vaccines to secure immunity for its entire populatio ...
HMD gets WHO-PQS certification for 0.3 ml Kojak AD Syringe, required for Pfizer’s vaccine expresspharma
January 04, 2021
The Hindustan Syringes and Medical Devices (HMD) receives the WHO- Performance, Quality and Safety (PQS) certification for its 0.3 ml Kojak AD Syringes, which are mainly required for the Pfizer’s Corona vaccine.
COVAX Alliance secures two billion doses of COVID-19 vaccines expresspharma
December 21, 2020
It aims to deliver 1.3 billion doses of approved vaccines next year to 92 eligible low- and middle-income economies.
Noncommunicable diseases are leading cause of death and disability worldwide, says WHO europeanpharmaceuticalreview
December 11, 2020
Alzheimer’s and diabetes enter the top ten global causes of death for the first time, while HIV/AIDS and tuberculosis deaths fall, according to the WHO’s 2019 Global Health Estimates.
COVID-19 vaccines will not be mandatory: WHO expresspharma
December 09, 2020
There may be some countries or some situations in countries where professional circumstances require it or highly recommend to be vaccinated.
Contributing to ACT Accelerator could generate $466 billion for major economies, says Eurasia Group report europeanpharmaceuticalreview
December 08, 2020
The report found that the 10 major economies could see a return of more than $466 billion by 2025, 12 times the total estimated cost of supporting the WHO’s Access to COVID-19 Tools (ACT) Accelerator.
WHO urges countries to “step up” the fight against malaria europeanpharmaceuticalreview
December 03, 2020
The WHO’s World malaria report suggests the progress in eradicating malaria has slowed due to funding shortages and that COVID-19 disruptions could result in additional deaths.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page